News

Neobiomics AB and Gennisium Pharma announce an exclusive collaboration for distribution of ProPrems® in France

Stockholm October 12, 2021 – Neobiomics and Gennisium Pharma have entered into a Distribution Agreement under which Gennisium has the exclusive rights to register, market and sell Neobiomics’ proprietary product ProPrems® in France, in effect immediately. ProPrems® is a high-quality product for safe food supplementation… Read More »Neobiomics AB and Gennisium Pharma announce an exclusive collaboration for distribution of ProPrems® in France